Evidence map›Paper›PMID 37246339›Full record

ArticleCancer2023

Experience with the US health care system for Black and White patients with advanced prostate cancer.

Emily M Rencsok, Konrad H Stopsack, Natalie Slopen, Folakemi T Odedina, Camille Ragin, Joel Nowak, Lawrence McSwain, Jan Manarite, Elisabeth Heath, Daniel J George and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Emily M RencsokDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-6935-1410
Konrad H StopsackDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Natalie SlopenDepartment of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Folakemi T OdedinaMayo Clinic Comprehensive Cancer Center, Jacksonville, Florida, USA.
Camille RaginFox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Joel NowakCancer ABCs, Brooklyn, New York, USA.
Lawrence McSwain
Jan ManariteCancer ABCs, Brooklyn, New York, USA.
Elisabeth HeathKarmanos Cancer Institute, Detroit, Michigan, USA.
Daniel J GeorgeDuke Cancer Institute, Durham, North Carolina, USA.ORCID 0000-0003-1499-7203
Philip W KantoffDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Jacob VinsonProstate Cancer Clinical Trials Consortium (PCCTC), New York, New York, USA.
Paul VillantiMovember Foundation, Melbourne, Australia.
Sebastien HaneuseDepartment of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0003-4963-0655
Lorelei A MucciDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
IRONMAN Registry
Harvard University · USSkin Cancer Foundation · USDuke Cancer InstituteFox Chase Cancer Center · USMemorial Sloan Kettering Cancer Center · USMovember Foundation · AUProstate Cancer Foundation · USProstate Cancer Research · GBThe Barbara Ann Karmanos Cancer Institute · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Racial disparities in advanced prostate cancer care: An analysis of treatment patterns and patient experienceF30CA264965 · NCI · HARVARD MEDICAL SCHOOL · PI RENCSOK, EMILY MAE · 2022 to 2025
$177k
NCI NIH HHS F30 CA264965NCI NIH HHS P30 CA008748NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

objectiveThe purpose of this study was to assess differences in reported information about treatment, integration into care, and respect by self-identified Black and White individuals with advanced prostate cancer in the United States. PATIENTS AND

methodsThis is a prospective cohort study of 701 participants (20% identifying as Black) enrolled in the International Registry for Men with Advanced Prostate Cancer at 37 US sites from 2017 to 2022. Participants were asked six questions from the Cancer Australia National Cancer Control Indicators about their experience with care at study enrollment. Prevalence differences by self-reported race were estimated using marginal standardization of logistic-normal mixed effects models (adjusted for age at enrollment and disease state at enrollment), and 95% CIs were estimated using parametric bootstrapping.

resultsMost participants reported a high quality of care for each question. Black participants generally reported higher care quality compared with White participants. Black participants reported more frequently that they were offered a written assessment and care plan (71%) compared with White participants (58%; adjusted difference, 13 percentage points; 95% CI, 4-23). Black participants also reported more frequently being given the name of nonphysician personnel who would support them (64%) than White participants (52%; adjusted difference, 10; 95% CI, 1-20). Prevalence differences did not differ by disease state at enrollment.

conclusionsBlack participants generally reported a higher quality of care compared with White participants. This study calls attention to the need to study potential mediating factors and interpersonal aspects of care in this population to improve survivorship.

Indexed as

Delivery of Health CareProstatic NeoplasmsBlack or African AmericanHumansMaleProspective StudiesUnited StatesWhiteinformation about treatmentintegration into carepatient experiencepatient preferenceprostate cancerracial disparities

Identifiers

PMID37246339
PMCPMC10524970
OpenAlexW4378640271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.